Gene Validity Classification Summary

Gene/Disease Pair:

GLA : Fabry disease

MONDO:0010526 | ORPHA:324 | OMIM:301500
Mode of Inheritance: X-linked inheritance (HP:0001427)
SOP: Gene Clinical Validity Standard Operating Procedures (SOP), Version 5

Genetic Evidence
Case-Level Data
Evidence Type Case Information Type Guidelines Scores PMIDs/Notes
Default Range Max Points Tally
Variant Evidence
Autosomal Dominant or X-linked Disorder Variant is de novo 2 0-3 12
Proband with predicted or proven null variant 1.5 0-2 10 8.50 8.5
Shimotori M et al. 2008 Feb (PMID:18205205); Topaloglu AK et al. 1999 Dec (PMID:10666480);
Proband with other variant type with some evidence of gene impact 0.5 0-1.5 7
11.00
7
Topaloglu AK et al. 1999 Dec (PMID:10666480); Shimotori M et al. 2008 Feb (PMID:18205205); Bernstein HS et al. 1989 Apr (PMID:2539398);
Autosomal Recessive Disease Two variants in trans and at least one de novo or a predicted/proven null variant 2 0-3 12
Two variants (not predicted/proven null) with some evidence of gene impact in trans 1 0-1.5
Segregation Evidence Evidence of segregation in one or more families   Sequencing Method 0-3 3
 
Total LOD Score Canditate Gene Sequencing Exome/Genome or all genes sequenced in linkage region  
2-2.99 0.5 1
3-4.99 1 2
≥5 1.5 3
Case-Control Data
Case-Control Study Type Case-Control Quality Criteria Guidelines Scores PMIDs/Notes
Points/Study Max Points Tally
Single Variant Analysis 1. Variant Detection Methodology
2. Power
3. Bias and confounding
4. Statistical Significance
0-6 12
Aggregate Variant Analysis 0-6
Total Genetic Evidence Points (Maximum 12) 12
Experimental Evidence
Evidence Category Evidence Type Guidelines Scores PMIDs/Notes
Default Range Max Points Tally
Function Biochemical Function 0.5 0 - 2 2
0.50
0.5
Brady RO et al. 1967 Mar 10 (PMID:6020428);
Protein Interaction 0.5 0 - 2
Expression 0.5 0 - 2
Functional Alteration Patient cells 1 0 - 2 2
0.50
0.5
Brady RO et al. 1967 May 25 (PMID:6023233);
Non-patient cells 0.5 0 - 1
Models Non-human model organism 2 0 - 4 4 2.00 4
Ohshima T et al. 1997 Mar 18 (PMID:9122231); Taguchi A et al. 2013 Dec 15 (PMID:24094090);
Cell culture model 1 0 - 2
Rescue Rescue in human 2 0 - 4
2.00
Beck M et al. 2015 Jun (PMID:26937390);
Rescue in non-human model organism 2 0 - 4
Rescue in cell culture model 1 0 - 2 1.00
Ohshima T et al. 1997 Mar 18 (PMID:9122231);
Rescue in patient cells 1 0 - 2
Total Experimental Evidence Points (Maximum 6) 5

 


 

Assertion criteria Genetic Evidence (0-12 points) Experimental Evidence
(0-6 points)
Total Points
(0-18)
Replication Over Time (Y/N)
Description Case-level, family segregation, or case-control data that support the gene-disease association Gene-level experimental evidence that support the gene-disease association Sum of Genetic & Experimental
Evidence
> 2 pubs w/ convincing evidence over time (>3 yrs)
Assigned Points 12 5 17 YES
CALCULATED CLASSIFICATION LIMITED 1-6
MODERATE 7-11
STRONG 12-18
DEFINITIVE 12-18 AND replication over time
Valid contradictory evidence (Y/N)*
NO
CALCULATED CLASSIFICATION (DATE)
DEFINITIVE
EXPERT CURATION (DATE)
DEFINITIVE
01/19/2018